Steven Marx, MD
Steven O. Marx, MD, is the director of the Cardiovascular Fellowship Program at Columbia University Medical Center/NewYork-Presbyterian Hospital, and is the director of the cardiology component of an NIH training grant for cardiology fellows and surgery residents.
His research program in cardiovascular diseases at Columbia has been focused in two major areas: molecular cardiology, particularly the regulation of ion channels in normal and pathological conditions in the heart, and vascular biology, particularly the molecular mechanisms of vascular smooth muscle proliferation, migration, and contractility. Working with others at Columbia, Marx has identified rapamycin (sirolimus) as a therapeutic agent for preventing restenosis after angioplasty/stent implantation. He also characterized the dysfunction of the ryanodine receptor in heart failure. A major focus of Marx’s current research is the regulation of arterial contractility and blood pressure by the ion channels.
The GICD/CVRI Seminar series is a collaborative series between the Gladstone Institute of Cardiovascular Disease and the Cardiovascular Research Institute at UC San Francisco.